Provided by Tiger Trade Technology Pte. Ltd.

Alnylam Pharmaceuticals

240.08
+4.071.72%
Post-market: 240.900.8200+0.34%19:09 EDT
Volume:1.58M
Turnover:376.81M
Market Cap:32.03B
PE:42.72
High:240.67
Open:236.56
Low:235.41
Close:236.01
52wk High:495.55
52wk Low:197.81
Shares:133.43M
Float Shares:133.16M
Volume Ratio:0.85
T/O Rate:1.18%
Dividend:- -
Dividend Rate:- -
EPS(TTM):5.62
EPS(LYR):2.33
ROE:96.55%
ROA:12.34%
PB:23.66
PE(LYR):103.04

Loading ...

Alnylam Pharmaceuticals, Inc. : H.c. Wainwright Cuts Target Price to $455 from $485

THOMSON REUTERS
·
Aug 04

U.S. Research Roundup-Cloudflare, Replimune, Walmart

Reuters
·
Aug 04

Movement Alert|Alnylam Pharmaceuticals Rises 5.47% in Regular Trading, Multiple Institutions Call Prior 28% Selloff Overdone

Market Focus
·
Aug 03

Alnylam Pharmaceuticals is Maintained at Overweight by Barclays

Dow Jones
·
Aug 03

Alnylam price target lowered to $450 from $527 at Barclays

TIPRANKS
·
Aug 03

Alnylam Pharmaceuticals Share Price Weakness Looks 'Overdone' Despite Softer Quarter, RBC Says

MT Newswires Live
·
Jul 31

RBC Cuts Price Target on Alnylam Pharmaceuticals to $350 From $445, Keeps Outperform Rating

MT Newswires Live
·
Jul 31

Analysts Conflicted on These Healthcare Names: Karyopharm Therapeutics (KPTI), Baxter International (BAX) and Alnylam Pharma (ALNY)

TIPRANKS
·
Jul 31

Alnylam price target lowered to $300 from $400 at Morgan Stanley

TIPRANKS
·
Jul 31

U.S. Research ROUNDUP-Apple, Amazon, Mastercard

Reuters
·
Jul 31

Alnylam Pharmaceuticals Inc : Needham Cuts Target Price to $357 from $510

THOMSON REUTERS
·
Jul 31

US Equity Markets End Higher on Microsoft's Cloud Gains, Semiconductor Rebound

MT Newswires Live
·
Jul 31

Neurocrine Biosciences Q2 Adjusted EPS Beats Expectations, Revenue Rises on Product Portfolio Growth

Reuters
·
Jul 31

Alnylam Pharmaceuticals is Maintained at Buy by Needham

Dow Jones
·
Jul 31

NASDAQ Top and Bottom Performing Stocks at About 02:45 P.m. EDT on 2026-07-30

Reuters
·
Jul 31

Alnylam Lowers 2026 Outlook As Second-Line Amvuttra Demand Normalizes, Stock Tanks

Benzinga Earnings
·
Jul 31

Alnylam Pharmaceuticals Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Jul 31

Top Midday Decliners

MT Newswires Live
·
Jul 31

H.C. Wainwright Sticks to Their Buy Rating for Alnylam Pharma (ALNY)

TIPRANKS
·
Jul 31

Analysts Offer Insights on Healthcare Companies: Bicycle Therapeutics (BCYC), Alnylam Pharma (ALNY) and Fortrea Holdings Inc. (FTRE)

TIPRANKS
·
Jul 31